7EAR image
Deposition Date 2021-03-08
Release Date 2021-04-28
Last Version Date 2023-11-29
Entry Detail
PDB ID:
7EAR
Keywords:
Title:
A positively charged mutant Cry3Aa endotoxin
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.21
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Crystaline entomocidal protoxin
Gene (Uniprot):cry3Aa
Mutations:N391K,N395K,E423K,Q430K,D432K,E433K,T436K,T461K,D462K,E463K,E466K
Chain IDs:A
Chain Length:644
Number of Molecules:1
Biological Source:Bacillus thuringiensis
Primary Citation
Efficient intracellular delivery of p53 protein by engineered protein crystals restores tumor suppressing function in vivo.
Biomaterials 271 120759 120759 (2021)
PMID: 33798968 DOI: 10.1016/j.biomaterials.2021.120759

Abstact

Direct delivery of proteins into cells holds significant potential for basic research and drug development. However, the poor endosomal escape of conventional delivery strategies remains a challenge, thus limiting the clinical translation of many protein therapeutics. Herein, we report that engineered Cry3Aa protein (Pos3Aa) crystals formed naturally within Bacillus thuringiensis can serve as a vehicle for efficient cytosolic delivery of bioactive proteins. We showed that Pos3Aa-mediated delivery of tumor suppressor p53 protein, a promising therapeutic candidate found to be inactivated in nearly half of human cancers, resulted in the restoration of p53 function in p53-deficient cancer cells, and thereby sensitized them to 5-fluorouracil chemotherapy as demonstrated in in vitro and in vivo models. Our results validate that Pos3Aa crystals can be a robust and effective platform for the cytosolic delivery of effector proteins, and suggest that efficient uptake and endosomal escape could be critical for efficacious p53 protein-based cancer therapy.

Legend

Protein

Chemical

Disease

Primary Citation of related structures